# Test-retest Study With [18F]FBB in Cardiac Amyloidosis

> **NCT06790394** · PHASE1 · RECRUITING · sponsor: **Life Molecular Imaging GmbH** · enrollment: 15 (estimated)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **DRUG:** Florbetaben F18

## Key facts

- **NCT ID:** NCT06790394
- **Lead sponsor:** Life Molecular Imaging GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790394, "Test-retest Study With [18F]FBB in Cardiac Amyloidosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06790394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*